TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Up 11.9% – Here’s Why

TriSalus Life Sciences, Inc. (NASDAQ:TLSIW)’s share price was up 11.9% on Monday . The stock traded as high as $0.88 and last traded at $0.8620. Approximately 356 shares were traded during mid-day trading, a decline of 93% from the average session volume of 5,311 shares. The stock had previously closed at $0.77.

TriSalus Life Sciences Price Performance

The business’s 50-day simple moving average is $0.74 and its 200-day simple moving average is $1.01.

Institutional Trading of TriSalus Life Sciences

Institutional investors have recently bought and sold shares of the company. Aristeia Capital L.L.C. acquired a new position in TriSalus Life Sciences in the 4th quarter worth about $43,000. Cerity Partners LLC acquired a new stake in shares of TriSalus Life Sciences during the 4th quarter valued at about $1,374,000. Citadel Advisors LLC grew its stake in shares of TriSalus Life Sciences by 439.0% in the 3rd quarter. Citadel Advisors LLC now owns 126,876 shares of the company’s stock valued at $199,000 after buying an additional 103,336 shares in the last quarter. Finally, Fort Baker Capital Management LP acquired a new position in TriSalus Life Sciences in the fourth quarter worth approximately $44,000.

TriSalus Life Sciences Company Profile

TriSalus Life Sciences, Inc is a clinical-stage medical device company focused on developing minimally invasive technologies to enhance the precision and efficacy of cancer radiation therapy. The company’s lead product, the TriMark™ Tissue Marker System, is designed to provide high-visibility soft-tissue fiducial markers that assist oncologists in accurately targeting tumors during radiotherapy. By deploying bio-absorbable markers directly into tumor beds, TriSalus aims to improve treatment planning, patient comfort and long-term follow-up imaging.

Founded in 2015 and headquartered in Plymouth, Minnesota, TriSalus Life Sciences pursues a platform approach to oncology treatment, with research and development efforts centered on novel delivery devices and advanced imaging solutions.